JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Dectrekumab is a fully human investigational anti-interleukin 13 monoclonal antibody, with anti-inflammatory potential. It was developed for asthma and seasonal allergic rhinitis.